1.4421

10.93% +0.1421

Protagenic Therapeutics Inc (PTIX)

Overview News Price History Financials Discussions Forecast Stock Split

Protagenic Therapeutics Inc stock is currently priced at $1.4421, with a 24-hour trading volume of 1,067. It has seen a +10.93% increased in the last 24 hours and a -14.67% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $1.31 pivot point. If it approaches the $1.37 resistance level, significant changes may occur.

Previous Close:

$1.30

Open:

$1.25

24h Volume:

1,067

Market Cap:

$5.77M

Revenue:

Net Income/Loss:

$-5.00M

P/E Ratio:

-1.8254

EPS:

-0.79

Net Cash Flow:

$-3.85M

1W Performance:

-8.07%

1M Performance:

-14.67%

6M Performance:

+80.24%

1Y Performance:

-24.10%

1D Range:

$1.25

$1.2804

52W Range:

$0.6797

$2.32

Protagenic Therapeutics Inc Stock (PTIX) Company Profile

Name

Protagenic Therapeutics Inc

Sector

Healthcare (1193)

Industry

Biotechnology (685)

Phone

212 994 8200

Address

149 Fifth Avenue, Suite 500, New York

Employee

Twitter

Next Earnings Date

2024-05-15

Latest SEC Filings

PTIX's Discussions on Twitter

Protagenic Therapeutics Inc Stock (PTIX) Financials Data

Protagenic Therapeutics Inc (PTIX) Net Income 2024

PTIX net income (TTM) was -$5.00 million for the quarter ending December 31, 2023, a -40.64% decrease year-over-year.

Protagenic Therapeutics Inc (PTIX) Cash Flow 2024

PTIX recorded a free cash flow (TTM) of -$3.85 million for the quarter ending December 31, 2023, a -93.28% decrease year-over-year.

Protagenic Therapeutics Inc (PTIX) Earnings per Share 2024

PTIX earnings per share (TTM) was -$1.15 for the quarter ending December 31, 2023, a -40.24% decline year-over-year.

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.